Fundz

PhotonPharma raised $2.5M in Seed funding to support the Phase I clinical trial of Innocell™, an innovative therapy for advanced ovarian cancer.

PRIVATEAug 22, 2024

Amount Raised

$2.5 Million

Round Type

Seed

Fort CollinsBiotechnology

Description

PhotonPharma, a biopharmaceutical company based in Fort Collins, CO, secured $2.5M in Seed funding. The funds will be used to advance the Phase I clinical trial of Innocell™, aimed at treating advanced ovarian cancer.

Who to call at PhotonPharma, and when

A new round usually means PhotonPharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PhotonPharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PhotonPharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PhotonPharma. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PhotonPharma

Location

3185 RAMPART ROAD

Fort Collins, Colorado, United States

About

PhotonPharma is dedicated to developing innovative autologous cancer therapies that leverage the body's immune system to fight disease. With a focus on personalized medicine, the company's lead product, Innocell™, aims to provide a safe and effective therapy for a wide range of solid organ tumors. In February 2024, PhotonPharma received FDA clearance for the company's first Phase 1 study in the US: a first-in-human clinical study for stage III/IV ovarian cancer treatment with the investigational autologous vaccine therapy, Innocell™. The company has partnered with the City of Hope in Los Angeles to conduct the study. The Phase 1 clinical trial for Innocell™ will evaluate its safety, tolerability, and immune response indicators in patients with Stage III/IV ovarian cancer. PhotonPharma anticipates initiating patient enrollment in the near future.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PhotonPharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAlan R., DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for PhotonPharma's next move

See what Strategic adds

PhotonPharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.